다운로드 iURO Oncology PC 용

PC를 설정하고 Windows 11에서 iURO Oncology 앱을 다운로드하는 단계:

1. 컴퓨터가 호환되는지 확인: 최소 요구 사항은 다음과 같습니다.
• RAM: 8GB (최저한의), 16GB (추천)
• 저장: SSD
• Processor:
• Intel Core i3 8th Gen (최소 이상)
• AMD Ryzen 3000 (최소 이상)
• Qualcomm Snapdragon 8c (최소 이상)
• Processor Architecture: x64 or ARM64
2. iURO Oncology 에 이미 기본 Windows 버전이 있는지 확인하십시오. 여기서 하세요 ». 기본 버전이 없으면 3단계로 진행합니다.

iURO Oncology is the must-have app for all uro-oncology healthcare professionals and students. The narrated simulation videos make it easy to understand and explain the different pathologies and therapies. It can be used by doctors and nurses to enhance communication with their patients. Medical students can use iURO apps to increase their knowledge and understanding of various urological and oncological topics. iURO Oncology can also be used by patients directly, to familiarize themselves with the different aspects of their oncological condition and the treatment options available. Features include: •Narrated simulation videos to explain prostate cancer, kidney cancer, bladder cancer and testicular cancer •Narrated simulation videos to explain different treatment options •Draw on picture, offering the opportunity to draw on and make personalized notes on a 3D image •Send this customized 3D image directly to patients or colleagues by email •360º image of the kidney, offering the opportunity to zoom on the 3D image from every angle iURO apps are created in consultation with urologists in order to provide a realistic representation of pathologies and therapies. iURO apps are prepared with the aim of enhancing communication and education options. If you are not a healthcare professional, please note that iURO apps support but never substitute the relation with your healthcare professional. App Management: •Scientific Director: Carlos Rioja, Hospital Royo Villanova, Zaragoza, Spain •Scientific Director: Jorge Rioja, Hospital Miguel Servet, Zaragoza, Spain •Scientific Director: Sanjeev Bandi, Mackay Urology, Mackay Australia iURO Scientific Advisory Board: Lithiasis •Olivier Traxer, University Pierre et Marie Curie Paris, France •Adrian Joyce, Spire Leeds Hospital in Roundhay, Leeds, Yorkshire, United Kingdom Benign Prostatic Hyperplasia •Jean de la Rosette, AMC University Hospital, Amsterdam, The Netherlands •Matthias Oelke, Hanover Medical School, Hanover, Germany Pelvic Floor Disorder, Functional and Female Urology •David Castro, University of La Laguna, Tenerife, Spain •Dirk De Ridder, Kliniekhoofd Urologie UZ, Leuven, Belgium Oncology •Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, USA •Raul Parra, Memorial Sloan Kettering Cancer Center, New York, USA •Peter Scardino, Memorial Sloan Kettering Cancer Center, New York, USA •Pilar Laguna, AMC University Hospital, Amsterdam •Sharokh Shariat, Weill Medical College of Cornell University, New York, USA •Theo de Reijke, AMC University Hospital Amsterdam, The Netherlands •Octavio Castillo Cadiz, Clínica Indisa, Santiago, Chile •Jaime Landman, University of California Irvine, Los Angeles, USA Andrology •Eduard Garcia, University Hospital Clícic de Barcelona, Barcelona, Spain •Juan Ignacio Martinez Salamanca, University Hospital Puerta de Hierro Majadahonda, Autonomous University of Madrid, Madrid, Spain •Ignacio Moncada, Hospital La Zarzuela, Madrid, Spain •David J Ralph, St Peter’s Andrology Centre, London, United Kingdom •Nelson Bennett, Lahey Hospital and Medical Center, Burlington, USA •Rados Djinovic, Sava Perovic Foundation, Belgrade, Serbia